Detailed view for Tb927.9.9390

Basic information

TDR Targets ID: 19689
Trypanosoma brucei, sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional
Source Database / ID:  TriTrypDB  GeneDB

pI: 8.1374 | Length (AA): 329 | MW (Da): 37180 | Paralog Number: 1

Signal peptide: Y | GPI Anchor: | Predicted trans-membrane segments: 5

Druggability Group : DG3

Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable

Pfam domains

PF14360   PAP2 superfamily C-terminal

Gene Ontology

Mouse over links to read term descriptions.
GO:0006686   sphingomyelin biosynthetic process  
GO:0047493   ceramide cholinephosphotransferase activity  
GO:0016020   membrane  

Metabolic Pathways

Sphingolipid metabolism (KEGG)
Global map (KEGG)

Structural information

Modbase 3D models:

There is 1 model calculated for this protein. More info on this model, including the model itself is available at: Modbase

Target Beg Target End Template Template Beg Template End Identity Evalue Model Score MPQS zDope
111 143 3tx3 (A) 36 87 36.00 0.3 0.2 0.202005 1.95

Help me make sense of these data.

Target Beg: first modeled residue
Target End: last modeled residue
Template: template structure used for modelling (PDB accession and chain)
Template Beg: first template residue in target-template alignment
Template End: last template residue in target-template alignment
Identity: sequence identity
Evalue: E value for target-template hit
Model Score: GA341 score (>0.7 for reliable model)
MPQS: ModPipe Quality Score (>1.1 for reliable model)
zDope: zDope Score (negative for reliable model)

A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.

PDB Structures:

No structure availble in the PDB for this protein

Expression

Upregulation Percent Ranking Stage Dataset
Mid 40-60% percentile Procyclic, Bloodstream Form. Siegel TN
Show/Hide expression data references
  • Siegel TN Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites.

Orthologs

Ortholog group members (OG5_139061)

Species Accession Gene Product
Leishmania braziliensis LbrM.34.4930   inositol phosphorylceramide synthase
Leishmania donovani LdBPK_355030.1   sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional
Leishmania infantum LinJ.35.5030   inositol phosphorylceramide synthase
Leishmania major LmjF.35.4990   phosphatidylcholine:ceramide cholinephosphotransferase 2
Leishmania mexicana LmxM.34.4990   hypothetical protein, conserved
Trypanosoma brucei gambiense Tbg972.9.5300   phosphatidylcholine:ceramide cholinephosphotransferase 2, putative
Trypanosoma brucei gambiense Tbg972.9.5330   phosphatidylcholine:ceramide cholinephosphotransferase 2, putative
Trypanosoma brucei gambiense Tbg972.9.5350   phosphatidylcholine:ceramide cholinephosphotransferase 2, putative
Trypanosoma brucei gambiense Tbg972.9.5340   phosphatidylcholine:ceramide cholinephosphotransferase 2, putative
Trypanosoma brucei Tb927.9.9380   sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional
Trypanosoma brucei Tb927.9.9390   sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional
Trypanosoma congolense TcIL3000_0_23730   sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional
Trypanosoma cruzi TcCLB.510729.290   sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional
Trypanosoma cruzi TcCLB.506885.124   sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional

Essentiality

Tb927.9.9390 has direct evidence of essentiality
Gene/Ortholog Organism Phenotype Source Study
Tb09.211.1000 Trypanosoma brucei no significant loss or gain of fitness in bloodstream forms (3 days) alsford
Tb09.211.1000 Trypanosoma brucei no significant loss or gain of fitness in bloodstream forms (6 days) alsford
Tb09.211.1000 Trypanosoma brucei no significant loss or gain of fitness in procyclic forms alsford
Tb09.211.1000 Trypanosoma brucei significant gain of fitness in differentiation of procyclic to bloodstream forms alsford
Tb09.211.1010 this record Trypanosoma brucei no significant loss or gain of fitness in bloodstream forms (3 days) alsford
Tb09.211.1010 this record Trypanosoma brucei significant loss of fitness in bloodstream forms (6 days) alsford
Tb09.211.1010 this record Trypanosoma brucei no significant loss or gain of fitness in procyclic forms alsford
Tb09.211.1010 this record Trypanosoma brucei no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms alsford
Show/Hide essentiality data references
  • goodall The Essential Genome of Escherichia coli K-12 (Transposon directed high-throughput mutagenesis) Goodall, Emily CA, et al. "The essential genome of Escherichia coli K-12." mBio 9.1 (2018): e02096-17.
  • wormbase C. elegans RNAi experiments WormBase web site, http://www.wormbase.org, release WS170
  • keio Systematic single-gene knock-out mutants of E. coli K12 The Keio Collection
  • nmpdr Genome-scale essentiality datasets from published studies (M. tuberculosis) National Microbial Pathogen Data Resource
  • gerdes Experimental determination and system-level analysis of essential genes in E. coli MG1655 Gerdes et al., J Bacteriol. 2003 185:5673-84
  • yeastgenome Systematic deletion of yeast genes Saccharomyces Genome Database
  • shigen Profiling of E. coli Chromosome (PEC) National Institute of Genetics, Japan
  • plasmo Functional Profiling of a Plasmodium Genome Reveals an Abundance of Essential Genes. Bushell, Ellen, et al. "Functional profiling of a Plasmodium genome reveals an abundance of essential genes." Cell 170.2 (2017): 260-272.
  • sidik A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes. Sidik, Saima M., et al. "A genome-wide CRISPR screen in toxoplasma identifies essential apicomplexan genes." Cell 166.6 (2016): 1423-1435.
  • blattner Systematic mutagenesis of the E. coli (MG1655) genome J Bacteriol 2004, 186:4921-4930
  • alsford High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome Genome Res 2011, 21:915-924
  • neb C. elegans RNAi phenotypes Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs

Phenotypes and Validation (curated)

Annotated phenotypes:

Affected Entity Phenotypic quality Occurs in Occurs at Evidence Observed in Drugs/Inhibitors
cell proliferation (GO:0008283) normal (PATO:0000461) bloodstream stage trypomastigotes (PLO:0027) inferred from RNAi experiment (ECO:0000019) No drug identifiers listed for this gene.
Annotator: fernan@iib.unsam.edu.ar. Comment: normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 3 days). References: 21363968
cell proliferation (GO:0008283) decreased (PATO:0000468) bloodstream stage trypomastigotes (PLO:0027) inferred from RNAi experiment (ECO:0000019) No drug identifiers listed for this gene.
Annotator: fernan@iib.unsam.edu.ar. Comment: decreased cell proliferation (significant loss of fitness) in bloodstream forms (stage 6 days). References: 21363968
cell proliferation (GO:0008283) normal (PATO:0000461) procyclic (PLO:0034) inferred from RNAi experiment (ECO:0000019) No drug identifiers listed for this gene.
Annotator: fernan@iib.unsam.edu.ar. Comment: normal cell proliferation (no significant loss or gain of fitness) in differentiation of procyclic to bloodstream forms . References: 21363968

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.

In any case, if you have information about papers containing relevant validation data for this target, please contact us.

Annotated validation

No validation data for this target

Associated compounds / Druggability

Known modulators for this target

No chemical compounds associated to this gene

Predicted associations

By orthology with druggable targets
Species Known druggable target Linked compounds Reference
Trypanosoma cruzi sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional Compounds References
Trypanosoma cruzi sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional Compounds References
By sequence similarity to non orthologous druggable targets
No additional associated druggable targets
Obtained from network model

Ranking Plot

Putative Drugs List

Compound Raw Global Species
0.046 0.5051 1
0.0527 0.4853 1
0.052 0.4918 1
0.0547 0.4842 0.4746
0.0529 0.4956 1
0.0516 0.4956 1
0.0512 0.5043 1
0.0452 0.2515 1
0.046 0.4883 1
0.0541 0.4853 1
0.0456 0.503 1
0.0117 0.4835 1
0.0181 0.4974 0.6962
0.0542 0.4903 1
0.0549 0.4924 1
0.0452 0.2515 1
0.0533 0.4909 1
0.0537 0.2515 1
0.0547 0.4842 0.4746
0.0549 0.5062 1
0.0449 0.5077 1
0.0464 0.3654 1
0.0451 0.2581 1
0.0447 0.5025 1
0.0549 0.4967 1
0.0459 0.4368 1
0.0511 0.4853 1
0.0557 0.4924 1
0.046 0.5051 1
0.0467 0.5036 1
0.0523 0.332 1
0.0467 0.5032 1
0.0467 0.5036 1
0.0467 0.488 1
0.0477 0.4853 1
0.0454 0.2773 1
0.046 0.5011 1
0.0488 0.4888 1
0.0456 0.503 1
0.0511 0.4853 1
0.0557 0.501 1
0.0459 0.4923 1
0.046 0.5051 1
0.0506 0.5054 1
0.047 0.4807 1
0.0513 0.4852 1
0.0482 0.4662 1
0.0484 0.4853 1
0.0475 0.4744 0.5
0.0457 0.2663 1
0.0181 0.4974 0.6962
0.048 0.48 0.5
0.0541 0.4853 1
0.0489 0.4825 1
0.0488 0.4978 1
0.0549 0.4924 1
0.0477 0.4853 1
0.0456 0.503 1
0.0511 0.4853 1
0.0456 0.503 1
0.048 0.5011 1
0.0508 0.4853 1
0.0446 0.4187 1
0.0477 0.4853 1
0.0557 0.4967 1
0.0506 0.5054 1
0.0445 0.3263 1
0.0549 0.4967 1
0.052 0.4918 1
0.0445 0.3263 1
0.0452 0.4103 1
0.0457 0.3263 1

Assayability

Assay information

No assay information for this target.

Reagent availability

No reagent availability information for this target.

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this gene, please enter them in a user comment (below) or Contact us.

User comments

No user comments are available for this gene. Log in to add comments, or register.

Enter your comment

User ()
Gene identifier Tb927.9.9390 (Trypanosoma brucei), sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional
Title for this comment
Comment